About 6,940,000 results
Mepolizumab reduces exacerbations in COPD with type 2 …
GSK announces positive results from phase III trial of Nucala ...
FDA Approves First Drug to Treat Group of Rare Blood Disorders in ...
GSK announces FDA approval for Nucala (mepolizumab) for …
Mepolizumab Significantly Reduces COPD Exacerbations
Benralizumab versus Mepolizumab for Eosinophilic …
FDA approves first drug for Eosinophilic Granulomatosis with ...
GSK achieves approval for Nucala (mepolizumab) for the …
GSK announces phase III results published in NEJM of mepolizumab …
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary …